USES OF MELANOCORTIN-3 RECEPTOR (MC3R) AGONIST PEPTIDES

The present invention provides methods of treating metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, methods of inducing weight loss and increasing muscle mass in a patient, by administration of MC3R agonist peptides. Further...

Full description

Saved in:
Bibliographic Details
Main Authors YAN, LIAN, ZENG, MAYER, JOHN, PHILIP, GADSKI, ROBERT, ALAN, HSIUNG, HANSEN, MAXWELL, HEIMAN, MARK, LOUIS
Format Patent
LanguageEnglish
French
German
Published 12.04.2006
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides methods of treating metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, methods of inducing weight loss and increasing muscle mass in a patient, by administration of MC3R agonist peptides. Furthermore, the present invention provides the use of an MC3R agonist peptide for the manufacture of a medicament for the treatment of metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, inducing weight loss and increasing muscle mass in a patient.
Bibliography:Application Number: EP20040753453